This information collection approval
request supports FDA guidance on the process for formally resolving
scientific and procedural disputes in the Center for Drug
Evaluation and Research and the Center for Biologics Evaluation and
Research that cannot be resolved at the division level. The
guidance describes procedures for formally appealing such disputes
to the office or center level and for submitting information to
assist center officials in resolving the issue(s)
presented.
US Code:
21 USC 301 et seq. Name of Law: Federal Food, Drug, and
Cosmetic Act
The information collection
reflects both changes and adjustment. We have decreased our burden
estimate by 14 responses and 112 hours based on the number of
dispute requests received since last OMB review.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.